Analyzing S100A6 expression in endoscopic ultrasonography-guided fine-needle aspiration specimens: A promising diagnostic method of pancreatic cancer

Journal of Clinical Gastroenterology

Volumn 47, Issue 1, 2013, Pages 69-75

  Zihao, Guo ^a   Jie, Zhang ^a   Yan, Liang ^a   Jing, Zhang ^a   Jing, Chen ^a   Xue, Li ^a,b   Jing, Zhu ^a   Heng, Li Wing ^c   Ru, Gao ^a   Jianyu, Hao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

diagnosis; EUS FNA; pancreatic ductal adenocarcinoma; RT PCR; S100A6

Indexed keywords

CALCYCLIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; IMMUNOHISTOLOGY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; CARCINOMA, PANCREATIC DUCTAL; CELL CYCLE PROTEINS; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84871614580     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182601752     Document Type: Article

References (32)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010 CA. Cancer J Clin. 2010;60:277-300.
2. National Cancer Institute: Surveillance Epidemiology and End Results Cancer Statistics Review 1975-2006. Available at: http://seer. cancer. gov/csr/1975-2006/. Accessed June 23, 2011.
3. NCCN Clinical Practice Guidelinesin Oncology (NCCN Guidelines TM). Pancreatic Adenocarcinoma, v. 1. 2010. Available at: http://www. nccn. org. Accessed September 2010.
4. Hunt GC, Faigel DO. Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc. 2002;55:232-237.
5. Mizuno N, Hara K, Hijioka S, et al. Current concept of endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. Pancreatology. 2011;11(suppl 2):40-46.
6. Eloubeidi MA, Varadarajulu S, Desai S, et al. Value of repeat endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic cancer. J Gastroenterol Hepatol. 2008;23:567-570.
7. Krishna NB, LaBundy JL, Saripalli S, et al. Diagnostic value of EUS-FNA in patients suspected of having pancreatic cancer with a focal lesion on CT scan/MRI but without obstructive jaundice. Pancreas. 2009;38:625-630.
8. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calcium-dependent and independent interactions of the S100 protein family. Biochem J. 2006;396:201-214.
9. Leśniak W, S"omnicki ŁP, Filipek A. S100A6-new facts and features. Biochem Biophys Res Commun. 2009;390:1087-1092.
10. Ohuchida K, Mizumoto K, Ishikawa N, et al. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res. 2005;11:7785-7793.
11. Vimalachandran D, Greenhalf W, Thompson C, et al. High nuclear S100A6 (calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res. 2005;65: 3218-3225.
12. Ohuchida K, Mizumoto K, Yu J, et al. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples. Cancer Epidemiol Biomarkers Prev. 2007;16:649-654.
13. Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003;63:2649-2657.
14. Black WC, Welch HG. Screening for disease. Am J Roentgenol. 1997;168:3-11.
15. Itoi T, Itokawa F, Sofuni A, et al. Puncture of solid pancreatic tumors guided by endoscopic ultrasonography: a pilot study series comparing trucut and 19-gauge and 22-gauge aspiration needle. Endoscopy. 2005;37:362-366.
16. Iwashita T, Yasuda I, Doi S, et al. The yield of endoscopic ultrasound-guided fine needle aspiration for histological diagnosis in patients suspected of stage I sarcoidosis. Endoscopy. 2008;40:400-405.
17. Kopelman Y, Marmor S, Ashkenazi I, et al. Value of EUSFNA cytological preparations compared with cell block sections in the diagnosis of pancreatic solid tumours. Cytopathology. 2011;22:174-178.
18. Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer. 2007;110:738-744.
19. Anderson MA, Brenner DE, Scheiman JM, et al. Reliable gene expression measurements from fine needle aspirates of pancreatic tumors: effect of amplicon length and quality assessment. J Mol Diagn. 2010;12:566-575.
20. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101-1108.
21. Glantz SA. Primer of Biostatistics. New York: McGraw-Hill Companies; 2006.
22. Hong Ho Y. Resampling methods: concepts, applications, and justification. Practical Assessment, Research & Evaluation. 2003;8:11-17.
23. Kamisawa T, Okazaki K, Kawa S. Diagnostic criteria for autoimmune pancreatitis in Japan. World J Gastroenterol. 2008;14:4992-4994.
24. Homma T, Harada H, Koizumi M. Diagnostic criteria of chronic pancreatitis by the Japan Pancreas Society. Pancreas. 1997;15:14-15.
25. Hartwig W, Schneider L, Diener MK, et al. Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg. 2009;96:5-20.
26. Kipp BR, Fritcher EG, Clayton AC, et al. Comparison of KRAS mutation analysis and FISH for detecting pancreaticobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography. J Mol Diagn. 2010;12:780-786.
27. Ren YX, Xu GM, Li ZS, et al. Detection of point mutation in K-ras oncogeneat codon 12 in pancreatic diseases. World J Gastroenterol. 2004;10:881-884.
28. Mishra G, Zhao Y, Sweeney J, et al. Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointest Endosc. 2006;63:648-654.
29. Wallace MB. Micrometastasis, molecular markers, and their future role with EUS-guided FNA. Gastrointest Endosc. 2009;69(2 suppl):S152-S154.
30. Fujita H, Ohuchida K, Mizumoto K, et al. High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Int J Oncol. 2011;38:629-641.
31. Ashida R, Nakata B, Shigekawa M, et al. Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer. J Exp Clin Cancer Res. 2009;28:83-86.
32. Nonogaki K, Itoh A, Kawashima H, et al. A preliminary result of three-dimensional microarray technology to gene analysis with endoscopic ultrasound-guided fine-needle aspiration specimens and pancreatic juices. J Exp Clin Cancer Res. 2010;29:36-40.